{"meta":{"query_hash":"04f387a918cf","filters":{"venue":"Journal of Chemotherapy"},"cohort_total":36,"direct_labels_cover":0,"predictions_cover":36,"exported":36,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/04f387a918cf","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Chemotherapy"},"results":[{"id":"W1970284883","doi":"10.1179/joc.2006.18.4.366","title":"Application of Two Methods to Determine Killing of<i>Streptococcus pneumoniae</i>by Various Fluoroquinolones","year":2006,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Streptococcus pneumoniae; Gatifloxacin; Moxifloxacin; Microbiology; Levofloxacin; Antimicrobial; Minimum inhibitory concentration; Ofloxacin; Drug; Antibiotics; Multiple drug resistance; Drug resistance; Streptococcaceae; Biology; Pharmacology; Ciprofloxacin","score_opus":0.011953478913849845,"score_gpt":0.334304866985249,"score_spread":0.3223513880713992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970284883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5220958,0.014944576,0.42933547,0.0011247981,0.0014494479,0.0073678712,0.00502239,0.0021271734,0.016532503],"genre_scores_gemma":[0.45234144,0.009525985,0.5076503,0.0010411664,0.00034688963,0.008613563,0.0059534307,0.00036593995,0.014161269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99041724,0.0022657136,0.0013104781,0.0018495708,0.003446794,0.00071018265],"domain_scores_gemma":[0.9919774,0.0025921387,0.0021733777,0.00094266544,0.0019188002,0.00039567443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002202568,0.0021199833,0.0017612024,0.0031735606,0.00059096975,0.0013650436,0.0015133324,0.0025040621,0.0025868115],"category_scores_gemma":[0.0047739986,0.0009555266,0.0014769919,0.002728054,0.0011321516,0.00093319244,0.0017610429,0.0027353521,0.0018228317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007755418,0.00068523054,0.0037593883,0.0008469162,0.00011165415,0.00006595472,0.00023272568,0.00027079936,0.9679069,0.0003601945,0.00040692763,0.024577849],"study_design_scores_gemma":[0.00007511139,0.0036202534,0.016858334,0.00007438364,0.00014832609,0.0011745343,0.00017387312,0.0028637033,0.97126514,0.00022129944,0.0033882959,0.00013680816],"about_ca_topic_score_codex":0.0018737422,"about_ca_topic_score_gemma":0.0025404138,"teacher_disagreement_score":0.0031735606,"about_ca_system_score_codex":0.0008389825,"about_ca_system_score_gemma":0.0007313089,"threshold_uncertainty_score":0.0116484165},"labels":[],"label_agreement":null},{"id":"W1974794853","doi":"10.1179/joc.2006.18.4.373","title":"Relative Potential for Selection of Quinolone-Resistance- Determining-Region Mutations in<i>Streptococcus pneumoniae</i>by Gemifloxacin, Gatifloxacin and Moxifloxacin","year":2006,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gatifloxacin; Gemifloxacin; Moxifloxacin; DNA gyrase; Quinolone; Streptococcus pneumoniae; Microbiology; Topoisomerase IV; Levofloxacin; Sparfloxacin; Ciprofloxacin; Medicine; Pharmacology; Biology; Antibiotics; Ofloxacin; Genetics; Escherichia coli; Gene","score_opus":0.007676465040214943,"score_gpt":0.26060307167367724,"score_spread":0.2529266066334623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974794853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919885,0.0002263044,0.00010911258,0.000020283172,0.0000042561846,0.0000053101235,0.0000613337,0.000008064266,0.00036647278],"genre_scores_gemma":[0.9987828,0.000114771305,0.0002927514,0.000019870276,0.0000051383586,0.0000069404728,0.00046690996,0.0000064272986,0.00030448326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951684,0.0001439418,0.000057620848,0.00006356253,0.00011333484,0.00010462065],"domain_scores_gemma":[0.9990305,0.00041382262,0.00012147413,0.000071463,0.00013260535,0.0002301883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038559406,0.000267468,0.00031970948,0.0002944278,0.00016362048,0.0005563823,0.00027401178,0.0004343828,0.00083019974],"category_scores_gemma":[0.0011344013,0.00017525928,0.00031109655,0.00015657334,0.00016929481,0.00025746654,0.00025469443,0.0004147498,0.00026792794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012551771,0.0001305819,0.009689971,0.000042714742,0.000027664375,0.00018323972,0.000047445144,0.00033835595,0.984829,0.00010329543,0.00007009585,0.0032824092],"study_design_scores_gemma":[0.00008302413,0.007279146,0.13360196,0.00003169608,0.00010779384,0.0023767743,0.00027967384,0.004929048,0.84948766,0.00009414356,0.0016852407,0.000043849013],"about_ca_topic_score_codex":0.0011558501,"about_ca_topic_score_gemma":0.0013384178,"teacher_disagreement_score":0.0011558501,"about_ca_system_score_codex":0.00030825078,"about_ca_system_score_gemma":0.00025221246,"threshold_uncertainty_score":0.0027772784},"labels":[],"label_agreement":null},{"id":"W1984982601","doi":"10.1179/joc.2007.19.5.546","title":"Comparative Cytotoxicity of C-1311 in Colon Cancer<i>In Vitro</i>and<i>In Vivo</i>Using the Hollow Fiber Assay","year":2007,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Capecitabine; Paclitaxel; Cytotoxicity; Growth inhibition; Colorectal cancer; In vivo; Cell growth; Chemotherapy; Pharmacology; Biology; MTT assay; Phases of clinical research; In vitro; Cancer research; Internal medicine; Cancer; Medicine; Biochemistry","score_opus":0.01857560441777594,"score_gpt":0.31279087514229365,"score_spread":0.2942152707245177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984982601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878149,0.0052290442,0.0037944224,0.00006891785,0.000027603297,0.000053709882,0.00043039038,0.000067527,0.0025136792],"genre_scores_gemma":[0.9842355,0.0037861667,0.0075749443,0.000059290647,0.000018115732,0.00006077795,0.0014243592,0.0000378943,0.0028028484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999691,0.00011714452,0.000019381001,0.00004836859,0.00008018551,0.000043824875],"domain_scores_gemma":[0.99968493,0.00011466493,0.000061615814,0.000026350557,0.00007578904,0.000036711066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032151223,0.00036155336,0.00029234562,0.00032298476,0.00021226975,0.0001876127,0.00013763324,0.00029447384,0.0009079454],"category_scores_gemma":[0.00027452322,0.00014511081,0.00019068568,0.0002661968,0.00022905551,0.00020153864,0.00010417548,0.0003375024,0.00031612662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028087816,0.000027672366,0.000411074,0.00006162636,0.000009647038,0.000032547887,0.000023238399,0.00028707815,0.99708027,0.000038365706,0.00004417028,0.0017033548],"study_design_scores_gemma":[0.000014100322,0.0012797154,0.0035693506,0.0000053310036,0.000018465558,0.0002683838,0.000019453935,0.0010551282,0.9929039,0.00001712776,0.0008414691,0.000007609971],"about_ca_topic_score_codex":0.0036232704,"about_ca_topic_score_gemma":0.00355711,"teacher_disagreement_score":0.0036232704,"about_ca_system_score_codex":0.00049146975,"about_ca_system_score_gemma":0.0003101066,"threshold_uncertainty_score":0.007204354},"labels":[],"label_agreement":null},{"id":"W1986405458","doi":"10.1179/joc.2011.23.1.32","title":"Trastuzumab and Vinorelbine in Early Stages of HER2-Positive Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Vinorelbine; Trastuzumab; Oncology; Medicine; Breast cancer; Internal medicine; Chemotherapy; Cancer; Cisplatin","score_opus":0.027853901849152547,"score_gpt":0.3377025580965879,"score_spread":0.30984865624743535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986405458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392235,0.0052791443,0.00013494607,0.0000923632,0.0000105764575,0.000016244097,0.000023100953,0.0000035713915,0.000517808],"genre_scores_gemma":[0.9983181,0.001090357,0.00018862428,0.00005680795,0.000022807233,0.000010680354,0.00006031785,0.0000010713176,0.0002511933],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997423,0.00016042033,0.0000118839835,0.000014976387,0.000034647965,0.00003571544],"domain_scores_gemma":[0.9997862,0.00009540471,0.00004277824,0.0000088480265,0.000008996246,0.00005783978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062519265,0.00013543347,0.0003603318,0.00011313583,0.00009237902,0.00014963836,0.00011923681,0.00015394534,0.0003890707],"category_scores_gemma":[0.0007837065,0.00007616179,0.00013864921,0.00012350605,0.00010757172,0.00012300654,0.00010783618,0.00030408174,0.00006002532],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081639305,0.0039319494,0.22035415,0.0004946022,0.0004987006,0.002636377,0.00029327697,0.003444283,0.056598708,0.00032496656,0.0016890311,0.6280947],"study_design_scores_gemma":[0.013930362,0.16958408,0.7530131,0.00014813761,0.00069708395,0.008711538,0.00018428253,0.004405578,0.028850676,0.00067109487,0.019760866,0.000043143813],"about_ca_topic_score_codex":0.00034048143,"about_ca_topic_score_gemma":0.0017244042,"teacher_disagreement_score":0.00062519265,"about_ca_system_score_codex":0.00024643436,"about_ca_system_score_gemma":0.00020553221,"threshold_uncertainty_score":0.0033063889},"labels":[],"label_agreement":null},{"id":"W1990911266","doi":"10.1179/joc.2007.19.2.146","title":"Antimicrobial Efficacy of Gatifloxacin and Moxifloxacin with and without Benzalkonium Chloride Compared with Ciprofloxacin and Levofloxacin Against Methicillin- Resistant<i>Staphylococcus aureus</i>","year":2007,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Gatifloxacin; Moxifloxacin; Benzalkonium chloride; Levofloxacin; Ciprofloxacin; Staphylococcus aureus; Microbiology; Antimicrobial; Medicine; Chemistry; Antibiotics; Bacteria; Biology","score_opus":0.014440794711889929,"score_gpt":0.2847500317379832,"score_spread":0.2703092370260933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990911266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921182,0.0071853544,0.00011761811,0.00007593627,0.000042509622,0.000017851695,0.000054419706,0.000014836544,0.00037341242],"genre_scores_gemma":[0.99623483,0.0023362115,0.0006422836,0.000098728444,0.000050806848,0.000015855441,0.00015805781,0.0000053953345,0.00045779793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950707,0.0001441874,0.00004329072,0.00008960249,0.00012730273,0.000088687724],"domain_scores_gemma":[0.9995764,0.000099975354,0.00013253579,0.000014461751,0.00005860356,0.00011807813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033006744,0.00049354194,0.00063714664,0.00021828075,0.00013722897,0.0003332629,0.00040624474,0.0005357984,0.0008523595],"category_scores_gemma":[0.00055681786,0.0001997817,0.00035773803,0.00018816127,0.0003152376,0.000285491,0.00014786764,0.00039097044,0.00019375168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054624222,0.0019484771,0.007544814,0.0009824131,0.00025344404,0.00026442978,0.00011332491,0.00073201564,0.8635114,0.00007918026,0.0004659884,0.06948035],"study_design_scores_gemma":[0.008815928,0.25031307,0.10514802,0.00018326283,0.00124706,0.0035221113,0.00029583005,0.0035722172,0.61892617,0.00010246228,0.007729047,0.00014473635],"about_ca_topic_score_codex":0.0023234908,"about_ca_topic_score_gemma":0.0038771434,"teacher_disagreement_score":0.0023234908,"about_ca_system_score_codex":0.0004053598,"about_ca_system_score_gemma":0.00044878188,"threshold_uncertainty_score":0.004619956},"labels":[],"label_agreement":null},{"id":"W1998609714","doi":"10.1179/joc.2009.21.1.16","title":"Antimicrobial Susceptibility Among Bacterial Isolates from ICU and Non-ICU Settings and Different Age Groups: Results from the Tigecycline Evaluation and Surveillance Trial in North America","year":2009,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Tigecycline; Linezolid; Medicine; Meropenem; Imipenem; Amikacin; Cefepime; Vancomycin; Acinetobacter baumannii; Microbiology; Antimicrobial; Antibiotics; Antibiotic resistance; Biology; Staphylococcus aureus","score_opus":0.007140946014033651,"score_gpt":0.24888068381567147,"score_spread":0.24173973780163782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998609714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752396,0.0015745902,0.000055958146,0.00008715647,0.000010359927,0.00005983131,0.00046697096,0.0000030758379,0.00021813514],"genre_scores_gemma":[0.99606353,0.0010703641,0.0002789264,0.0003509018,0.00004543909,0.00010665186,0.0018429582,0.000005367307,0.0002358425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977441,0.0012892109,0.0001989226,0.00027327743,0.00028028677,0.0002142722],"domain_scores_gemma":[0.9957806,0.0009628704,0.001514402,0.00015880688,0.0005827003,0.0010005204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029837522,0.00045875937,0.0008545198,0.0005601544,0.0002666146,0.0004815935,0.0003361643,0.0007166789,0.000633311],"category_scores_gemma":[0.0031400628,0.00035579375,0.0006524514,0.00087333645,0.00031406048,0.00035453402,0.0003323586,0.0007793858,0.00010528069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06882795,0.0026051945,0.8920772,0.0004151765,0.0015941766,0.00046744972,0.000747932,0.0003495942,0.0080517735,0.000035651465,0.0019701363,0.022857795],"study_design_scores_gemma":[0.004493743,0.010637742,0.9825622,0.000039260314,0.00035328118,0.0003130689,0.00018399826,0.00022757445,0.000579351,0.000016390095,0.000577072,0.000016237718],"about_ca_topic_score_codex":0.0043514525,"about_ca_topic_score_gemma":0.011893484,"teacher_disagreement_score":0.0043514525,"about_ca_system_score_codex":0.0005675331,"about_ca_system_score_gemma":0.0007542558,"threshold_uncertainty_score":0.015779734},"labels":[],"label_agreement":null},{"id":"W2004481186","doi":"10.1179/joc.2009.21.5.527","title":"Prescription of Antibiotics in Intensive Care Units in Latin America: An Observational Study","year":2009,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Observational study; Medical prescription; Antibiotics; Medicine; Intensive care medicine; Latin Americans; Intensive care; Antibacterial agent; Internal medicine; Pharmacology; Biology; Microbiology; Political science","score_opus":0.06077571461327468,"score_gpt":0.3142668172654434,"score_spread":0.25349110265216873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004481186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991171,0.00024073882,0.000044650045,0.00006668515,0.0000030285448,0.000012497438,0.00022582797,0.0000022879742,0.00028732212],"genre_scores_gemma":[0.9990752,0.00029475917,0.000077509205,0.00010232395,0.000011250596,0.000020195528,0.00034567912,0.0000024186734,0.000070752794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919754,0.0003191871,0.00010356472,0.00013154872,0.0001327328,0.00011556675],"domain_scores_gemma":[0.9963806,0.0006679765,0.001964256,0.00016951475,0.00032191354,0.00049574586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008408862,0.00033384227,0.00051290944,0.0009966732,0.00043592986,0.0009821956,0.00051685795,0.00075604045,0.0010388686],"category_scores_gemma":[0.0029366226,0.00046529,0.00039749304,0.0017488752,0.00045485602,0.000816286,0.00067704933,0.00071348454,0.00023749078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039659226,0.00005994838,0.99907553,0.000011926076,0.000024478257,0.00006623207,0.00016201877,0.000009976305,0.00006740074,0.00000570157,0.00005037118,0.0004268064],"study_design_scores_gemma":[0.00000994149,0.000104547675,0.99866724,0.000016284921,0.000012702052,0.00019689344,0.0007135416,0.00009138974,0.000014007855,0.0000069924977,0.00016210985,0.000004301208],"about_ca_topic_score_codex":0.016991273,"about_ca_topic_score_gemma":0.016110703,"teacher_disagreement_score":0.016991273,"about_ca_system_score_codex":0.0007924892,"about_ca_system_score_gemma":0.00062416063,"threshold_uncertainty_score":0.033784688},"labels":[],"label_agreement":null},{"id":"W2013519952","doi":"10.1179/1973947812y.0000000063","title":"<i>In vitro</i>activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics","year":2013,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Microbiology; Antibiotics; Staphylococcus aureus; Minimum inhibitory concentration; In vitro; Methicillin-resistant Staphylococcus aureus; Biology; Daptomycin; Pharmacology; Chemistry; Bacteria; Biochemistry; Vancomycin","score_opus":0.008365583363074948,"score_gpt":0.24989124071399746,"score_spread":0.24152565735092252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013519952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865507,0.004863329,0.0029859755,0.00010603449,0.000065067106,0.0000647427,0.0012957151,0.000118076765,0.0039504194],"genre_scores_gemma":[0.992834,0.0013351117,0.0022010014,0.000059685262,0.000028826063,0.00004599759,0.0016577138,0.000017570677,0.0018200148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996245,0.00012883158,0.000038061924,0.00004963046,0.00008307869,0.000075928634],"domain_scores_gemma":[0.9997142,0.00012411067,0.000055949702,0.000025365835,0.00004860049,0.000031815765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034229815,0.00040127806,0.0003570879,0.0002106156,0.00010102825,0.00020823363,0.00023594318,0.000304769,0.0010892504],"category_scores_gemma":[0.000464753,0.00013386259,0.00028858607,0.00023422603,0.00015775453,0.0001840555,0.000108445405,0.0003705374,0.00028049538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013980361,0.00014571051,0.0007426712,0.00011197067,0.000023737004,0.000050458693,0.00003491161,0.00086440484,0.9911383,0.000075651464,0.00042220636,0.0049919225],"study_design_scores_gemma":[0.000022695685,0.0028253456,0.002885016,0.000007125038,0.000021295222,0.00012199075,0.000014910691,0.0023651265,0.9906474,0.000014231898,0.0010671903,0.0000077467785],"about_ca_topic_score_codex":0.0033623162,"about_ca_topic_score_gemma":0.002022652,"teacher_disagreement_score":0.0033623162,"about_ca_system_score_codex":0.00033689852,"about_ca_system_score_gemma":0.00018454035,"threshold_uncertainty_score":0.0066854954},"labels":[],"label_agreement":null},{"id":"W2014158951","doi":"10.1179/joc.2005.17.6.593","title":"Antimicrobial Spectrum and Potency of Dalbavancin Tested Against Clinical Isolates from Europe and North America (2003): Initial Results from an International Surveillance Protocol","year":2005,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dalbavancin; Teicoplanin; Dalfopristin; Quinupristin; Microbiology; Enterococcus faecium; Linezolid; Broth microdilution; Vancomycin; Enterococcus; Glycopeptide; Staphylococcus aureus; Penicillin; Streptococcus pneumoniae; Medicine; Minimum inhibitory concentration; Antimicrobial; Biology; Antibiotics; Bacteria","score_opus":0.018932889955184665,"score_gpt":0.33111863844811984,"score_spread":0.3121857484929352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014158951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9395294,0.0025069574,0.0056299632,0.00041896687,0.0000687628,0.014477706,0.024979273,0.00021330945,0.012175713],"genre_scores_gemma":[0.87356174,0.0032124403,0.018609682,0.0012394689,0.000098371456,0.018294761,0.07938877,0.000081029975,0.0055137365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758744,0.0008277868,0.0005396193,0.0003951836,0.00048755936,0.00016240381],"domain_scores_gemma":[0.99612623,0.00036216856,0.0006611825,0.00032204014,0.0021676228,0.00036075764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031273302,0.0010349778,0.00060017616,0.0011276755,0.0005131791,0.0006331719,0.0015436515,0.00076190894,0.0017208355],"category_scores_gemma":[0.0030862628,0.00027284987,0.0004707869,0.0013861483,0.00031088365,0.0003332114,0.00048242972,0.0003860325,0.000676743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026067281,0.009482612,0.6154891,0.0015211949,0.0003980277,0.001499686,0.0029014808,0.0018941716,0.18893945,0.00048271255,0.017575094,0.1337491],"study_design_scores_gemma":[0.0016161256,0.020693352,0.86023265,0.00024375238,0.00030050302,0.0021950023,0.0009663787,0.0007462608,0.07478799,0.0000832239,0.03807612,0.000058635127],"about_ca_topic_score_codex":0.0063687824,"about_ca_topic_score_gemma":0.0072458168,"teacher_disagreement_score":0.99363124,"about_ca_system_score_codex":0.0010084473,"about_ca_system_score_gemma":0.0013986796,"threshold_uncertainty_score":0.016539156},"labels":[],"label_agreement":null},{"id":"W2015258308","doi":"10.1179/joc.2008.20.1.126","title":"<i>Capnocytophaga</i>spp. DF-1 Pneumonia in an Immune-Competent 56-Year Old Man Post-CABG","year":2008,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Capnocytophaga; Pneumonia; Medicine; Bypass grafting; Flavobacteriaceae; Antibiotics; Artery; Microbiology; Internal medicine; Biology; Bacteria","score_opus":0.021763404368015844,"score_gpt":0.2984383201941854,"score_spread":0.2766749158261696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015258308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003168037,0.99167013,0.00042411053,0.0006949136,0.00079617824,0.000012067759,0.000022645052,0.00002422863,0.0031877225],"genre_scores_gemma":[0.016466608,0.9781345,0.00067306083,0.0009847304,0.0013835412,0.000011950039,0.00006891228,0.000004569794,0.0022722057],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99986064,0.000027014814,0.000027246175,0.000023973636,0.00004207649,0.00001898704],"domain_scores_gemma":[0.9998436,0.00005399329,0.00003975589,0.000004689773,0.00003848084,0.000019360346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021265142,0.0006409055,0.0007242575,0.0009886053,0.00017074868,0.00039677182,0.0004659207,0.00089681835,0.0009920615],"category_scores_gemma":[0.00037087806,0.00013959188,0.00026227982,0.0007244691,0.0002807873,0.0005675542,0.00022639941,0.00063913997,0.0013287776],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001282501,0.000085621316,0.0042336644,0.009935989,0.0000806101,0.02266963,0.00013518926,0.00017709944,0.0070444047,0.0005217729,0.036475,0.91851276],"study_design_scores_gemma":[0.00003503829,0.0006846233,0.023785332,0.0047143777,0.00029230196,0.29358548,0.00038530026,0.00027436716,0.004141256,0.0007782771,0.6712699,0.000053848304],"about_ca_topic_score_codex":0.00087766186,"about_ca_topic_score_gemma":0.0014031489,"teacher_disagreement_score":0.0009920615,"about_ca_system_score_codex":0.00022547803,"about_ca_system_score_gemma":0.0002997572,"threshold_uncertainty_score":0.0033187866},"labels":[],"label_agreement":null},{"id":"W2025742951","doi":"10.1179/joc.2007.19.4.392","title":"Antipneumococcal Activity of Ertapenem Compared with Gatifloxacin in a Temperature-Sensitive Murine Model of Acute Pneumonia","year":2007,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gatifloxacin; Ertapenem; Streptococcus pneumoniae; Microbiology; Pneumonia; Medicine; Pneumolysin; Antibiotics; Internal medicine; Biology; Levofloxacin; Antibiotic resistance; Meropenem","score_opus":0.012728562962916192,"score_gpt":0.2852792858877311,"score_spread":0.2725507229248149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025742951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963213,0.0018942073,0.0003910939,0.000115547715,0.00007897854,0.00006622224,0.0003263579,0.00004438655,0.0007618227],"genre_scores_gemma":[0.99215937,0.0025510858,0.0014409004,0.00009809537,0.00009380003,0.00011255445,0.00077469874,0.000026476646,0.0027430053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994949,0.00017137204,0.000048001028,0.00005857554,0.00009321381,0.0001339698],"domain_scores_gemma":[0.9995472,0.000071750794,0.00012512117,0.000045306893,0.000052579326,0.00015806196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043964153,0.00081699574,0.0012167733,0.0005228439,0.00019759833,0.0003980751,0.00040474028,0.0006332784,0.0016992496],"category_scores_gemma":[0.00034433676,0.00034994833,0.00046638525,0.0002611791,0.00041374937,0.00056925125,0.0001767893,0.0014879155,0.00029579378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018523572,0.00198902,0.0005746134,0.00029308273,0.000066895795,0.00011740813,0.000059455644,0.00040513478,0.9685107,0.000092515205,0.0002652293,0.009102463],"study_design_scores_gemma":[0.0013395036,0.07365165,0.007984808,0.000046147623,0.00017025995,0.00046215628,0.000060093098,0.0015356854,0.9133808,0.000059481645,0.0012783426,0.000031086616],"about_ca_topic_score_codex":0.00093258533,"about_ca_topic_score_gemma":0.001855982,"teacher_disagreement_score":0.0016992496,"about_ca_system_score_codex":0.0003464392,"about_ca_system_score_gemma":0.00033033156,"threshold_uncertainty_score":0.005684495},"labels":[],"label_agreement":null},{"id":"W2031621781","doi":"10.1179/joc.2011.23.6.326","title":"Thalidomide: An Old Drug with New Action","year":2011,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Thalidomide; Immune system; Medicine; Drug; Tuberculosis; Cancer; Mode of action; Immunology; Drug action; Pathogenesis; Pharmacology; Biology; Pathology; Multiple myeloma; Internal medicine","score_opus":0.1237648748996664,"score_gpt":0.4159307699631318,"score_spread":0.29216589506346535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031621781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017048298,0.99804026,0.000105939616,0.00055333815,0.00025426465,0.0000025551576,0.000007617409,0.0000051438406,0.0008605256],"genre_scores_gemma":[0.001161863,0.99734515,0.00019284316,0.00032735599,0.0003193108,0.0000031440532,0.000012556846,9.291322e-7,0.00063694565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986506,0.000022109505,0.000018677218,0.000023429495,0.000059074955,0.000011610016],"domain_scores_gemma":[0.9998677,0.00005430775,0.000018699582,0.0000046119126,0.00003568934,0.00001903186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003061056,0.0005058178,0.000872026,0.0013360484,0.0003501145,0.00077525835,0.0004994365,0.000798787,0.0019599716],"category_scores_gemma":[0.00039333853,0.00015399407,0.0002640112,0.0012719351,0.0005952666,0.0012499272,0.0004442626,0.0015882931,0.0010782065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007090076,0.000056055032,0.00023390591,0.0077108108,0.00003987377,0.00041415624,0.00010235622,0.00014406514,0.002692477,0.0051484657,0.03145212,0.95193475],"study_design_scores_gemma":[0.000013948529,0.00007607896,0.0005708554,0.0013165862,0.00004037442,0.0023506538,0.000048575886,0.00005177241,0.00052778004,0.0016091939,0.9933837,0.000010402713],"about_ca_topic_score_codex":0.0007103102,"about_ca_topic_score_gemma":0.00145805,"teacher_disagreement_score":0.0019599716,"about_ca_system_score_codex":0.0006174987,"about_ca_system_score_gemma":0.0006665387,"threshold_uncertainty_score":0.006556809},"labels":[],"label_agreement":null},{"id":"W2032103745","doi":"10.1179/joc.2004.16.5.419","title":"Future Trends in Antimicrobial Chemotherapy: Expert Opinion on the 43<sup>rd</sup>ICAAC","year":2004,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Antimicrobial; Antimicrobial chemotherapy; Expert opinion; Antibiotics; Streptococcus pneumoniae; Daptomycin; Antibiotic resistance; Medicine; Cephalosporin; Intensive care medicine; Microbiology; Biology; Bacteria; Vancomycin; Staphylococcus aureus","score_opus":0.018444235841749007,"score_gpt":0.31493077058964375,"score_spread":0.29648653474789477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032103745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007853532,0.9737707,0.00023314737,0.01226457,0.011156367,0.000011523248,0.00003437439,0.00001607274,0.0024348046],"genre_scores_gemma":[0.0008820261,0.9727591,0.00065151835,0.009467416,0.011538476,0.00002487724,0.00010475687,0.0000053293816,0.0045663854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992212,0.00016288323,0.00010550174,0.00009132661,0.00034921855,0.000069840215],"domain_scores_gemma":[0.9978302,0.0006834269,0.00021131254,0.00005150702,0.0009791617,0.00024433355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015138555,0.0010534318,0.0015491394,0.0018006191,0.00045822925,0.0019678327,0.0015080064,0.0040242723,0.012552023],"category_scores_gemma":[0.0033835776,0.00029880478,0.00074438885,0.0026809576,0.000717002,0.0034376464,0.00084406626,0.0030037744,0.008264212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096121286,0.000045917706,0.00023171848,0.0053452845,0.000048603455,0.00030556927,0.00004357213,0.00019347174,0.00049124606,0.0017151078,0.42221522,0.56926805],"study_design_scores_gemma":[0.000019505751,0.00003130559,0.00042630697,0.0023312704,0.000043465043,0.0007989373,0.0000561072,0.000057253717,0.000081397615,0.001064565,0.9950777,0.0000121394505],"about_ca_topic_score_codex":0.0013793055,"about_ca_topic_score_gemma":0.0035851267,"teacher_disagreement_score":0.012552023,"about_ca_system_score_codex":0.0014479816,"about_ca_system_score_gemma":0.0020396789,"threshold_uncertainty_score":0.041990697},"labels":[],"label_agreement":null},{"id":"W2039702214","doi":"10.1179/joc.2006.18.6.582","title":"Gemifloxacin for the Management of Community-Acquired Respiratory Tract Infections","year":2006,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Gemifloxacin; Streptococcus pneumoniae; Respiratory tract infections; Medicine; Antibiotics; Antimicrobial; Intensive care medicine; Antibacterial agent; Respiratory tract; Antibiotic resistance; Microbiology; Respiratory system; Biology; Internal medicine","score_opus":0.08463538580862333,"score_gpt":0.3956732234291914,"score_spread":0.3110378376205681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039702214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038164796,0.9984438,0.000110918765,0.00014306682,0.000104020415,0.0000067995497,0.000010559559,0.000012469938,0.0007867175],"genre_scores_gemma":[0.0034729561,0.9948598,0.00036476762,0.00018468959,0.00015850367,0.000012111147,0.000042802087,0.000002519962,0.00090176985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984205,0.000039497754,0.000025347774,0.000022613574,0.00005356511,0.000016930859],"domain_scores_gemma":[0.9997621,0.000088222456,0.00006256434,0.0000063623893,0.000042604708,0.000038177834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046009113,0.0007820257,0.0014398696,0.0022197254,0.0002758303,0.00054888014,0.00092420063,0.0012066632,0.0035937119],"category_scores_gemma":[0.00054279173,0.00018128703,0.00043473905,0.0017351619,0.00038314564,0.00083110953,0.00035198565,0.001354579,0.0025355623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025561117,0.00014514755,0.00023548453,0.009426755,0.00009375695,0.00077587937,0.000052666113,0.00027798823,0.0022028915,0.00060156884,0.020163288,0.96576893],"study_design_scores_gemma":[0.00026403548,0.0007872231,0.0037723987,0.0045613237,0.00035926534,0.013049039,0.00012329411,0.0002808494,0.0022715158,0.000875828,0.97362137,0.000033902747],"about_ca_topic_score_codex":0.0015421933,"about_ca_topic_score_gemma":0.0031870522,"teacher_disagreement_score":0.0035937119,"about_ca_system_score_codex":0.0004521695,"about_ca_system_score_gemma":0.00068840175,"threshold_uncertainty_score":0.012022197},"labels":[],"label_agreement":null},{"id":"W2062358462","doi":"10.1179/joc.2000.12.4.360","title":"A Pilot Study of Low Dose Hydroxyurea as a Novel Resistance Modulator in Metastatic Renal Cell Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Vinblastine; Neutropenia; Medicine; Chemotherapy; Renal cell carcinoma; Internal medicine; Gastroenterology; Toxicity; Febrile neutropenia; Cancer; Pharmacology; Urology; Oncology","score_opus":0.026772745466838936,"score_gpt":0.29582095655836016,"score_spread":0.2690482110915212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062358462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718094,0.0011895177,0.0003228648,0.00011770083,0.000043413384,0.0004674419,0.000055368135,0.000020909181,0.0006018466],"genre_scores_gemma":[0.99702483,0.0010463141,0.0006371468,0.00014252111,0.00009016528,0.00033097484,0.00018213922,0.000009858973,0.00053601235],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99950445,0.00026287662,0.000023785042,0.00006611078,0.00004484517,0.000097878954],"domain_scores_gemma":[0.9993631,0.00017354047,0.00006109642,0.00005712904,0.000042247622,0.00030280114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009726325,0.0005456325,0.0012898976,0.0003143636,0.0005923618,0.00060175936,0.00095722504,0.00072539516,0.0021118612],"category_scores_gemma":[0.00096518284,0.00023920699,0.0006466619,0.00043343953,0.00091741484,0.0005197471,0.00032125055,0.0017911018,0.00033358394],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21551782,0.1747959,0.017226892,0.0013335384,0.0008512414,0.004156811,0.001803314,0.0032583836,0.3826368,0.0006835456,0.0021711476,0.19556458],"study_design_scores_gemma":[0.03055249,0.9380689,0.01193758,0.000024873894,0.00023397086,0.0009366005,0.00013160461,0.0006409124,0.01495343,0.00010350749,0.002395117,0.000021004209],"about_ca_topic_score_codex":0.0011826296,"about_ca_topic_score_gemma":0.0025944668,"teacher_disagreement_score":0.0021118612,"about_ca_system_score_codex":0.00053187733,"about_ca_system_score_gemma":0.0010798718,"threshold_uncertainty_score":0.007064879},"labels":[],"label_agreement":null},{"id":"W2072065071","doi":"10.1179/joc.2006.18.6.634","title":"Short-Course Therapy of Gemifloxacin Effective Against Pneumococcal Pneumonia in Mice","year":2006,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gemifloxacin; Pneumonia; Pneumococcal pneumonia; Medicine; Short course; Streptococcus pneumoniae; Antibacterial agent; Pneumococcal infections; Intensive care medicine; Microbiology; Antibiotics; Internal medicine; Biology; Pediatrics","score_opus":0.00816311570671026,"score_gpt":0.2794562789509019,"score_spread":0.27129316324419167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072065071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951674,0.0019583628,0.0009586255,0.00012101918,0.000099152654,0.00012682592,0.00052277965,0.00013759382,0.00090826774],"genre_scores_gemma":[0.99317193,0.001048103,0.002638378,0.0001599016,0.000053813972,0.00019162426,0.0009150421,0.00002679272,0.0017944392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995889,0.00009150907,0.000032490047,0.000069478076,0.000059367587,0.00015828336],"domain_scores_gemma":[0.9996106,0.000055615958,0.000103670594,0.000047049372,0.00003255489,0.00015055815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004041034,0.00045110693,0.00078181777,0.00030570166,0.00018195773,0.00034450277,0.0005557272,0.0008896756,0.00064855],"category_scores_gemma":[0.00020109177,0.00022319025,0.00041484216,0.00015799976,0.00033110814,0.00042092957,0.00017145395,0.0011496472,0.00026405224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004351214,0.0012556894,0.00054684427,0.00008209203,0.00003269181,0.00004725766,0.000026913383,0.00024032217,0.9863614,0.0000641895,0.00026301207,0.0067284494],"study_design_scores_gemma":[0.0006066076,0.045909118,0.008213175,0.000021901214,0.0000823305,0.00020227158,0.000036343714,0.0015908435,0.94088995,0.000057568446,0.002368992,0.00002095804],"about_ca_topic_score_codex":0.00066792243,"about_ca_topic_score_gemma":0.002112791,"teacher_disagreement_score":0.0008896756,"about_ca_system_score_codex":0.0004928363,"about_ca_system_score_gemma":0.00043281756,"threshold_uncertainty_score":0.0035758018},"labels":[],"label_agreement":null},{"id":"W2076658666","doi":"10.1179/joc.2010.22.5.304","title":"Telavancin Activity Against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections","year":2010,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microbiology; Vancomycin; Teicoplanin; Staphylococcus aureus; Enterococcus faecium; Enterococcus faecalis; Antimicrobial; Biology; Minimum inhibitory concentration; Antibiotics; Bacteria","score_opus":0.002813237421578932,"score_gpt":0.22552120982455384,"score_spread":0.2227079724029749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076658666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994655,0.0029764855,0.00020315142,0.00014815338,0.000026917203,0.000061168605,0.00020243353,0.000036836183,0.0016898202],"genre_scores_gemma":[0.9983467,0.0007109506,0.00020582574,0.00009354756,0.000015383699,0.000010133928,0.00023548555,0.000003256687,0.00037882663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997695,0.000059454636,0.000036503472,0.00003656092,0.00005540704,0.00004259743],"domain_scores_gemma":[0.99965036,0.000102583814,0.00004651599,0.000010257612,0.000082451836,0.00010781966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022883655,0.00026733062,0.0004258805,0.00020259636,0.000101405734,0.00028009104,0.00015289162,0.00021425413,0.0017306438],"category_scores_gemma":[0.0008508583,0.00008217595,0.00018795936,0.00023682688,0.00012065471,0.00017646897,0.00021085893,0.0005598782,0.0002007611],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024817731,0.0029845303,0.08956275,0.001795965,0.00044265907,0.0036450517,0.0007506274,0.0010330818,0.6039736,0.00019211728,0.0025958004,0.2682061],"study_design_scores_gemma":[0.0052668913,0.112666115,0.4970593,0.0002824593,0.00070933177,0.01801363,0.0011582433,0.0030510756,0.34474084,0.00018622582,0.016767269,0.000098676544],"about_ca_topic_score_codex":0.0006672073,"about_ca_topic_score_gemma":0.0015045274,"teacher_disagreement_score":0.0017306438,"about_ca_system_score_codex":0.00018699138,"about_ca_system_score_gemma":0.00024749915,"threshold_uncertainty_score":0.005789578},"labels":[],"label_agreement":null},{"id":"W2081243791","doi":"10.1179/joc.2005.17.5.484","title":"Comparison of the Minimum Inhibitory, Mutant Prevention and Minimum Bactericidal Concentrations of Ciprofloxacin, Levofloxacin and Garenoxacin Against Enteric Gram-negative Urinary Tract Infection Pathogens","year":2005,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Ciprofloxacin; Microbiology; Levofloxacin; Enterobacter cloacae; Citrobacter freundii; Klebsiella pneumoniae; Minimum inhibitory concentration; Pseudomonas aeruginosa; Trimethoprim; Antimicrobial; Ampicillin; Gatifloxacin; Antibiotics; Chemistry; Escherichia coli; Biology; Bacteria","score_opus":0.020036855920303794,"score_gpt":0.30640325725933426,"score_spread":0.28636640133903046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081243791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959996,0.0026761736,0.0004726746,0.000046236095,0.00001630617,0.000013405761,0.00015451164,0.00001981952,0.00060136145],"genre_scores_gemma":[0.99727386,0.0006249007,0.0014263933,0.000030798783,0.000010473403,0.000019236,0.00033373837,0.000005440494,0.00027520172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991503,0.00024228981,0.0001010653,0.00013592989,0.00028222223,0.00008820799],"domain_scores_gemma":[0.99844885,0.0006579949,0.0003744495,0.00006150237,0.00028683658,0.00017031367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042123484,0.00046351505,0.00036261513,0.0002558339,0.00010143523,0.00045187972,0.00030532505,0.00057358353,0.00047606684],"category_scores_gemma":[0.0027005945,0.00018675388,0.00019715833,0.00024183937,0.00028807038,0.0003343146,0.00018144475,0.00029632388,0.00013716264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028220634,0.00037776367,0.012680371,0.00038116626,0.00006166378,0.00006660708,0.000120487064,0.0012184856,0.9575099,0.000093996096,0.00023648246,0.024431055],"study_design_scores_gemma":[0.00016122551,0.015180346,0.10512775,0.000059367634,0.00012994577,0.00071984855,0.00018277067,0.0030832877,0.87290835,0.00009958928,0.0023012778,0.00004631729],"about_ca_topic_score_codex":0.00079602073,"about_ca_topic_score_gemma":0.0009670302,"teacher_disagreement_score":0.00079602073,"about_ca_system_score_codex":0.0001778823,"about_ca_system_score_gemma":0.00024789353,"threshold_uncertainty_score":0.0022277832},"labels":[],"label_agreement":null},{"id":"W2082551934","doi":"10.1179/joc.2000.12.4.299","title":"Assessment of the Susceptibility of<i>Streptococcus pneumoniae</i>to Cefaclor and Loracarbef in 13 Countries","year":2000,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cefaclor; Penicillin; Streptococcus pneumoniae; Microbiology; Antibacterial agent; Antibiotics; Medicine; Cephalosporin; Biology","score_opus":0.0073321996998420265,"score_gpt":0.29890369986538057,"score_spread":0.29157150016553857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082551934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864846,0.00051337614,0.0000809612,0.00001687168,0.00000222361,0.0000135131595,0.00021164744,0.000005013511,0.0005078066],"genre_scores_gemma":[0.9985959,0.00029707604,0.0004056767,0.000043881824,0.0000041702424,0.000016520704,0.0005463325,0.0000029098048,0.00008757599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849486,0.00050725206,0.00023335071,0.00025603425,0.00023211158,0.00027643118],"domain_scores_gemma":[0.9964838,0.0005926857,0.0017530536,0.00015535112,0.00073931745,0.00027568475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001429011,0.00044619924,0.000453014,0.001052167,0.00039793339,0.00094042264,0.0003745285,0.00046731846,0.00039515982],"category_scores_gemma":[0.0033064664,0.00053529255,0.00035717848,0.0010761183,0.0005846084,0.0003818954,0.0005794714,0.00039119992,0.00019471899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024077971,0.000029854345,0.9917344,0.000047867707,0.000055824803,0.00021347185,0.00032507695,0.00015526942,0.0017747965,0.00001269255,0.00011314193,0.0052967677],"study_design_scores_gemma":[0.00002157108,0.0005082175,0.99517834,0.00003128801,0.000039604784,0.0010132,0.00074301055,0.00011910098,0.0013115417,0.000009321994,0.0010154725,0.000009267269],"about_ca_topic_score_codex":0.0062281536,"about_ca_topic_score_gemma":0.0064401585,"teacher_disagreement_score":0.0062281536,"about_ca_system_score_codex":0.0006607651,"about_ca_system_score_gemma":0.0004195167,"threshold_uncertainty_score":0.012383819},"labels":[],"label_agreement":null},{"id":"W2096525901","doi":"10.1179/1973947812y.0000000039","title":"ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries","year":2012,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Linezolid; Enterococcus faecium; Microbiology; Broth microdilution; Enterococcus faecalis; Clindamycin; Staphylococcus aureus; Streptococcus pneumoniae; Enterococcus; cons; Medicine; Biology; Antibiotics; Minimum inhibitory concentration; Vancomycin; Bacteria","score_opus":0.04291486435139032,"score_gpt":0.3980938916812837,"score_spread":0.35517902732989337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096525901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861994,0.0005928893,0.0005534052,0.0000660792,0.000012355672,0.0002591365,0.010310786,0.000084190215,0.001921656],"genre_scores_gemma":[0.9721066,0.0006024927,0.003601804,0.000103958635,0.00002432805,0.00032397395,0.022028513,0.000024795698,0.0011835799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809605,0.00043264808,0.0003080142,0.0002811788,0.0006712523,0.00021082548],"domain_scores_gemma":[0.9968707,0.0003076513,0.0010697426,0.00010352358,0.0014410039,0.0002074105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002358358,0.0005963086,0.0004643726,0.0021077814,0.00031345742,0.00072255847,0.00035040185,0.0002798471,0.00062380225],"category_scores_gemma":[0.0026679756,0.0003696032,0.0004661777,0.0018455804,0.00019017201,0.00036837644,0.0007176973,0.00026512032,0.00032463972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011032191,0.00024760305,0.94674194,0.00038203553,0.00018042873,0.0001840788,0.00087432424,0.000632364,0.008480103,0.00005242714,0.0028169402,0.038304456],"study_design_scores_gemma":[0.000036949765,0.00071193743,0.99377054,0.000017649876,0.000059495094,0.00015440155,0.00019362231,0.00019017307,0.0022902049,0.0000050614294,0.0025609676,0.000008962641],"about_ca_topic_score_codex":0.013832938,"about_ca_topic_score_gemma":0.015521663,"teacher_disagreement_score":0.013832938,"about_ca_system_score_codex":0.0011584576,"about_ca_system_score_gemma":0.0012860689,"threshold_uncertainty_score":0.027504802},"labels":[],"label_agreement":null},{"id":"W2104290226","doi":"10.1179/1973947812y.0000000062","title":"Detection, treatment, and prevention of carbapenemase-producing<i>Enterobacteriaceae</i>: Recommendations from an International Working Group","year":2013,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Etest; Colistin; Broth microdilution; Carbapenem; Carbapenem-resistant enterobacteriaceae; Agar dilution; Minimum inhibitory concentration; Medicine; Enterobacteriaceae; Regimen; Antimicrobial; Microbiology; Antibiotics; Aminoglycoside; Internal medicine; Pharmacology; Biology","score_opus":0.012974411680582942,"score_gpt":0.27702930224890004,"score_spread":0.2640548905683171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104290226","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016456814,0.39646134,0.08553832,0.42573607,0.01724272,0.0061596544,0.0055405097,0.0019763324,0.04488832],"genre_scores_gemma":[0.05269794,0.38139772,0.4320531,0.08781978,0.0059727575,0.0076631485,0.007691072,0.0007134551,0.023991046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912601,0.0029572384,0.0020759073,0.0003922293,0.0028018,0.00051269995],"domain_scores_gemma":[0.97563237,0.0038438877,0.0034638697,0.0007525873,0.0138653265,0.0024418677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014414384,0.0028402049,0.0025718503,0.004573962,0.0011272567,0.001655081,0.0049161008,0.0062358524,0.0023038075],"category_scores_gemma":[0.015607284,0.0009855753,0.0031628578,0.0023813331,0.0019005067,0.001761925,0.00186432,0.0059535378,0.0029384033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000517417,0.0022396937,0.013070776,0.010469636,0.00037628858,0.000986027,0.00078497926,0.0020107182,0.009483171,0.0023093682,0.3529277,0.6048241],"study_design_scores_gemma":[0.00059475744,0.0018346842,0.077569745,0.02949164,0.0014847094,0.0031269758,0.0020353636,0.0022670564,0.010707095,0.0058283405,0.86474556,0.00031413842],"about_ca_topic_score_codex":0.013469993,"about_ca_topic_score_gemma":0.015545801,"teacher_disagreement_score":0.014414384,"about_ca_system_score_codex":0.002090756,"about_ca_system_score_gemma":0.012269796,"threshold_uncertainty_score":0.07623148},"labels":[],"label_agreement":null},{"id":"W2409698911","doi":"10.1080/1120009x.2002.11782349","title":"Prevalence and Characterization of Macrolide Resistance in Clinical Isolates of <i>Streptococcus pneumoniae</i> and <i>Streptococcus pyogenes</i> from North America","year":2002,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Manitoba Health","funders":"","keywords":"Streptococcus pyogenes; Telithromycin; Ketolide; Streptococcus pneumoniae; Erythromycin; Microbiology; Efflux; Biology; Drug resistance; Macrolide Antibiotics; Antibacterial agent; Antibiotics; Bacteria; Genetics; Staphylococcus aureus","score_opus":0.013928914784051253,"score_gpt":0.2695377202944711,"score_spread":0.25560880551041987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409698911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780875,0.0006256173,0.00011919949,0.00011109851,0.0000073315086,0.00003078622,0.00045595932,0.000008151952,0.00083306007],"genre_scores_gemma":[0.9978728,0.0006871401,0.0002537758,0.00015969395,0.000014692732,0.000028324224,0.00071059883,0.0000052916744,0.0002676197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991072,0.00017096136,0.00013048072,0.00020219503,0.00022234117,0.00016676598],"domain_scores_gemma":[0.9986896,0.00024235368,0.00033804373,0.00007132222,0.00045309638,0.00020558525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004560289,0.00021985338,0.00030625623,0.0015151484,0.00062260305,0.0008105163,0.0004817519,0.0006124942,0.000736775],"category_scores_gemma":[0.0018831266,0.0003238734,0.00017719787,0.0011617347,0.0005227141,0.00039615712,0.00031655762,0.00038852438,0.00024628098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001068593,0.000082439125,0.9849948,0.00005153308,0.000026472117,0.0003567098,0.0010236269,0.000032400956,0.0065323343,0.00003664894,0.0004501322,0.006305977],"study_design_scores_gemma":[0.00000599461,0.00010198571,0.99537575,0.00001786275,0.000013516858,0.0015120951,0.0011989244,0.00007476064,0.0007160275,0.000013570927,0.0009635277,0.00000598527],"about_ca_topic_score_codex":0.061404787,"about_ca_topic_score_gemma":0.06419913,"teacher_disagreement_score":0.061404787,"about_ca_system_score_codex":0.0008617706,"about_ca_system_score_gemma":0.0007912499,"threshold_uncertainty_score":0.12209475},"labels":[],"label_agreement":null},{"id":"W2411994009","doi":"10.1080/1120009x.2004.11782402","title":"Resistance Trends in <i>Haemophilus influenzae</i> (PROTEKT Years 1–3 [1999–2002])","year":2004,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Haemophilus influenzae; Microbiology; Pasteurellaceae; Resistance (ecology); Medicine; Biology; Antibiotics; Ecology","score_opus":0.013490655221886503,"score_gpt":0.2883297120216597,"score_spread":0.27483905679977316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411994009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162439,0.002026943,0.00016224454,0.0004805877,0.00005650523,0.00006866446,0.07935118,0.000046860387,0.0015631537],"genre_scores_gemma":[0.9344778,0.0012954014,0.0005565509,0.00030732524,0.000058512593,0.00010510843,0.06159682,0.0000138735395,0.001588633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997094,0.00004253552,0.00005388369,0.000057410223,0.00007438821,0.00006234524],"domain_scores_gemma":[0.99855345,0.00008181712,0.0008103198,0.00005254414,0.00031948555,0.00018240786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058069546,0.00031299365,0.00028291688,0.0010934059,0.000318831,0.00054981315,0.00058961863,0.0006592752,0.0012653411],"category_scores_gemma":[0.0013958286,0.00031154114,0.00058160117,0.0018837892,0.0001198334,0.00050501374,0.00047544306,0.0007210895,0.0004145107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053469534,0.00010213733,0.98470646,0.000076561264,0.00016736191,0.000111924164,0.00013538911,0.00024090115,0.00050227845,0.000027018055,0.007798841,0.0055965204],"study_design_scores_gemma":[0.000013077065,0.000048496786,0.9990595,0.000011307051,0.000037208498,0.000096986114,0.0000393318,0.00006060115,0.00008094286,0.0000037464133,0.0005459675,0.0000028636236],"about_ca_topic_score_codex":0.12094824,"about_ca_topic_score_gemma":0.17798842,"teacher_disagreement_score":0.12094824,"about_ca_system_score_codex":0.00088846585,"about_ca_system_score_gemma":0.0009048963,"threshold_uncertainty_score":0.24048853},"labels":[],"label_agreement":null},{"id":"W2419028065","doi":"10.1080/1120009x.2001.11782329","title":"Infectious Diseases: Career Preparation","year":2001,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Infectious disease (medical specialty); Medicine; Global health; Political science; Economic growth; Disease; Public health; Nursing; Pathology","score_opus":0.03428793942170228,"score_gpt":0.42249251665926185,"score_spread":0.3882045772375596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419028065","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020355621,0.03875652,0.004996636,0.433476,0.050762556,0.001560359,0.001118047,0.0006664306,0.44830778],"genre_scores_gemma":[0.1177622,0.06441876,0.016630484,0.08734621,0.021066776,0.0013384448,0.002404572,0.0003176615,0.6887149],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552876,0.0014183067,0.00027661142,0.00022045647,0.0012460679,0.0013096908],"domain_scores_gemma":[0.95772284,0.0013151668,0.001326584,0.00062062236,0.0056723393,0.03334247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065123043,0.00083066296,0.0005684139,0.0021228571,0.005258829,0.0055723446,0.0012281477,0.0027829236,0.08066205],"category_scores_gemma":[0.015182901,0.00041411194,0.00051568996,0.0012946695,0.0011225593,0.0019794144,0.0070412224,0.0038022143,0.044798806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041141564,0.00029721233,0.0037057577,0.00039376813,0.0000041982526,0.0002654634,0.0009061245,0.0001004839,0.0003130269,0.0035429855,0.80601543,0.18441436],"study_design_scores_gemma":[0.000027511347,0.00024751975,0.011626176,0.0011066386,0.000004208734,0.0010660703,0.0025142587,0.00010873729,0.00014726684,0.0056073023,0.9775235,0.000020774201],"about_ca_topic_score_codex":0.002015021,"about_ca_topic_score_gemma":0.006699978,"teacher_disagreement_score":0.08066205,"about_ca_system_score_codex":0.00276499,"about_ca_system_score_gemma":0.025007458,"threshold_uncertainty_score":0.26984143},"labels":[],"label_agreement":null},{"id":"W2428638391","doi":"10.1080/1120009x.2001.11782324","title":"Community Acquired Pneumonia (CAP): An Update","year":2001,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; University of Manitoba; Mount Sinai Hospital","funders":"","keywords":"Community-acquired pneumonia; Pneumonia; Pneumonia severity index; Intensive care medicine; Empiric treatment; Etiology; Medicine; Internal medicine; Antibiotics; Biology","score_opus":0.07410428960654857,"score_gpt":0.3937359718405865,"score_spread":0.31963168223403793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428638391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017641138,0.99698406,0.00009734356,0.0006515206,0.0009898462,0.000008862585,0.000036972015,0.000014436741,0.0010404993],"genre_scores_gemma":[0.0005458097,0.99719363,0.0002625276,0.0004594686,0.0007663099,0.000009418714,0.000067714966,0.0000018945235,0.0006932874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999469,0.0000953767,0.00011734422,0.00006681559,0.00021592109,0.000035571284],"domain_scores_gemma":[0.9984901,0.0006299815,0.00020122709,0.00004368332,0.000458801,0.00017604815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011886611,0.001350176,0.0028132107,0.0041144304,0.00040381114,0.0016899736,0.001739294,0.0021319422,0.006165546],"category_scores_gemma":[0.0022199398,0.00044472466,0.00082097505,0.0044174385,0.00047740992,0.003014518,0.0008049411,0.0016936566,0.003787866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008886859,0.00008851444,0.0004443114,0.013142504,0.00010178258,0.00052179664,0.000056868786,0.0001791668,0.000380908,0.00070846576,0.09821318,0.88607365],"study_design_scores_gemma":[0.000047338774,0.00011540016,0.0019100145,0.0062669744,0.00023535885,0.004196472,0.000082034276,0.0000933674,0.000109151,0.0005810088,0.9863418,0.000021002466],"about_ca_topic_score_codex":0.0028335438,"about_ca_topic_score_gemma":0.0070269215,"teacher_disagreement_score":0.006165546,"about_ca_system_score_codex":0.0009434134,"about_ca_system_score_gemma":0.0020131164,"threshold_uncertainty_score":0.02062577},"labels":[],"label_agreement":null},{"id":"W2474139679","doi":"10.1080/1120009x.2001.11782321","title":"Infectious Diseases on the 21<sup>st</sup> Century Doorstep","year":2001,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Modalities; Infectious disease (medical specialty); Health professionals; Medicine; Clinical microbiology; Disease; Health care; Political science; Sociology; Biology; Pathology; Microbiology; Social science","score_opus":0.015752972708512246,"score_gpt":0.30370404730233436,"score_spread":0.28795107459382213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474139679","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036489724,0.091326416,0.0025080692,0.714396,0.10846007,0.00004804096,0.00031012474,0.0006155503,0.078686744],"genre_scores_gemma":[0.046575196,0.17003861,0.009718097,0.4144282,0.08697109,0.000109782624,0.00065322703,0.0003686216,0.2711372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974802,0.0005560548,0.00021720042,0.00016748258,0.0011682918,0.00041074093],"domain_scores_gemma":[0.9903841,0.002903784,0.00067008956,0.0005960864,0.0020237782,0.003422029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003392241,0.0006730035,0.0008431933,0.0007295635,0.002278605,0.0078869155,0.0008889324,0.0049402746,0.0763913],"category_scores_gemma":[0.009536249,0.000361995,0.0005342608,0.0007580482,0.0034047866,0.0069904835,0.004067303,0.006669636,0.03536553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007023504,0.000061379214,0.0014196801,0.00034920845,0.000022443628,0.0003201728,0.0003705096,0.00008870568,0.0008029657,0.025157806,0.7869224,0.18441439],"study_design_scores_gemma":[0.0000053649305,0.00002868423,0.0010065621,0.0003310178,0.000005580896,0.00031817128,0.0007818951,0.000024684681,0.00008468581,0.0056512044,0.9917503,0.000011802053],"about_ca_topic_score_codex":0.0015580812,"about_ca_topic_score_gemma":0.0045733345,"teacher_disagreement_score":0.0763913,"about_ca_system_score_codex":0.0013532367,"about_ca_system_score_gemma":0.0035137984,"threshold_uncertainty_score":0.25555438},"labels":[],"label_agreement":null},{"id":"W2766177920","doi":"10.1080/1120009x.2017.1389807","title":"Effect of vancomycin initial dosing on time to systemic inflammatory response syndrome resolution in patients with methicillin-resistant <i>Staphylococcus aureus</i> bacteremia","year":2017,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Vancomycin; Medicine; Bacteremia; Systemic inflammatory response syndrome; Staphylococcus aureus; Dosing; Sepsis; Internal medicine; Cohort; Hazard ratio; Methicillin-resistant Staphylococcus aureus; Surgery; Gastroenterology; Anesthesia; Antibiotics; Microbiology","score_opus":0.0070124187867246215,"score_gpt":0.2736180815291428,"score_spread":0.2666056627424182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766177920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940145,0.0003020977,0.000057831967,0.000027150782,0.000011555458,0.000015593212,0.000028335355,0.0000029253708,0.00015309114],"genre_scores_gemma":[0.999696,0.000083526356,0.00007383311,0.000026005979,0.000011660691,0.000008319425,0.00004704859,0.0000012599708,0.00005237704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907184,0.00042279458,0.000088826055,0.00014199116,0.00010862768,0.00016591285],"domain_scores_gemma":[0.9951945,0.0018380773,0.0016657556,0.00034307525,0.00016293308,0.0007956146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016255351,0.00036917903,0.00082285085,0.00019817476,0.00021885072,0.00082762045,0.00025895005,0.0004598877,0.00080344407],"category_scores_gemma":[0.0059932186,0.00023167537,0.0009492356,0.00020535904,0.00025385537,0.00039610008,0.0002610407,0.0009213537,0.0001396707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13826852,0.0030262233,0.8008699,0.00011921561,0.001040239,0.00042463513,0.00024391079,0.0012167642,0.00858555,0.000067069974,0.00043631258,0.045701716],"study_design_scores_gemma":[0.0024701306,0.06366888,0.9285974,0.000034913774,0.0005179605,0.0004010004,0.00016527092,0.0018812885,0.0018158775,0.000075513635,0.00033467938,0.00003721478],"about_ca_topic_score_codex":0.00070660684,"about_ca_topic_score_gemma":0.00094832847,"teacher_disagreement_score":0.0016255351,"about_ca_system_score_codex":0.0004332695,"about_ca_system_score_gemma":0.0004891101,"threshold_uncertainty_score":0.008596778},"labels":[],"label_agreement":null},{"id":"W3128010065","doi":"10.1080/1120009x.2021.1879581","title":"Recovery of borderline oxacillin-resistant <i>Staphylococcus pseudintermedius</i> (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the family dog","year":2021,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Staphylococcus pseudintermedius; Clindamycin; Medicine; Erythromycin; Rheumatoid arthritis; Arthritis; Osteoporosis; Staphylococcus aureus; Antibiotics; Surgery; Dermatology; Internal medicine; Staphylococcus; Microbiology; Biology; Bacteria","score_opus":0.0063899664519588145,"score_gpt":0.2287528434200178,"score_spread":0.222362876968059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128010065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379784,0.0009095346,0.0007750569,0.0009278167,0.000060933395,0.000051071984,0.0000927412,0.000033335193,0.0033517664],"genre_scores_gemma":[0.9984717,0.00035326145,0.00035295755,0.0002765595,0.00007667836,0.000005092755,0.000042791966,0.0000060758807,0.00041496826],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995572,0.000060844097,0.000047244466,0.000096408396,0.000102926424,0.00013538897],"domain_scores_gemma":[0.9992188,0.00018818026,0.00019840212,0.000045443267,0.00007314867,0.00027596415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020119514,0.00094813376,0.00059279555,0.001109865,0.0015847393,0.0008234398,0.0005427752,0.002310872,0.0014166685],"category_scores_gemma":[0.0017229618,0.0006232282,0.0006619847,0.000440211,0.0010671355,0.00053681317,0.00079902075,0.0015226621,0.0005056093],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000124831,0.00008336548,0.038564745,0.000053416734,0.000013539808,0.95352864,0.00071005564,0.00005628845,0.004714087,0.00012385494,0.00029581907,0.001731364],"study_design_scores_gemma":[0.00001678711,0.0003818435,0.026168577,0.000032494,0.000029906912,0.96935016,0.00061299605,0.0002820091,0.0022693784,0.00011690652,0.0007228254,0.000016069658],"about_ca_topic_score_codex":0.002642769,"about_ca_topic_score_gemma":0.002281521,"teacher_disagreement_score":0.002642769,"about_ca_system_score_codex":0.0005067373,"about_ca_system_score_gemma":0.0004996574,"threshold_uncertainty_score":0.0052547455},"labels":[],"label_agreement":null},{"id":"W3212713753","doi":"10.1080/1120009x.2021.1995251","title":"Urinary tract infection in a human male patient with <i>Staphylococcus pseudintermedius</i> transmission from the family dog","year":2021,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Urinary system; Transmission (telecommunications); Adult male; Animal model","score_opus":0.010989878641154053,"score_gpt":0.2687635005438797,"score_spread":0.2577736219027257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212713753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980976,0.0025913818,0.0015502342,0.0033564556,0.00024476342,0.00008342051,0.00023036594,0.00013627646,0.010831239],"genre_scores_gemma":[0.9966253,0.0006477696,0.00053200324,0.00089770247,0.000291529,0.000008163176,0.000052105428,0.000011127792,0.00093428924],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995933,0.000076108365,0.000039129063,0.00011353349,0.00006533535,0.000112673704],"domain_scores_gemma":[0.9989795,0.00035848867,0.00020756817,0.000047642978,0.000060569088,0.00034618803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019746799,0.00088855345,0.0008592424,0.0011062941,0.001822725,0.001061761,0.0004104238,0.0032191346,0.0026608745],"category_scores_gemma":[0.001617124,0.0006609761,0.000724134,0.0005320165,0.0010076755,0.0010123893,0.0006812477,0.0017205898,0.0005174828],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091587295,0.00013659461,0.035700932,0.0000623777,0.000018927507,0.9574489,0.000746216,0.000099516765,0.0023594783,0.00024350577,0.0008420356,0.0022499608],"study_design_scores_gemma":[0.000009607339,0.00039444448,0.017115872,0.000036308862,0.000020967635,0.9799469,0.00038080165,0.0002711811,0.00082371145,0.0000970828,0.00088434154,0.000018799929],"about_ca_topic_score_codex":0.0018261864,"about_ca_topic_score_gemma":0.0020120495,"teacher_disagreement_score":0.0032191346,"about_ca_system_score_codex":0.0005445002,"about_ca_system_score_gemma":0.000565918,"threshold_uncertainty_score":0.008901477},"labels":[],"label_agreement":null},{"id":"W4390978892","doi":"10.1080/1120009x.2024.2302736","title":"Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer","year":2024,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"American Society of Hematology","keywords":"Food and drug administration; Medicine; Refractory (planetary science); Clinical trial; Lung cancer; Drug approval; Intensive care medicine; Family medicine; Drug; Oncology; Internal medicine; Medical emergency; Pharmacology","score_opus":0.04827015999822119,"score_gpt":0.42860374637497983,"score_spread":0.3803335863767586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390978892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014250171,0.9994154,0.000028922774,0.00009559515,0.000050446062,0.000010113054,0.000034376793,0.000001946991,0.0002206916],"genre_scores_gemma":[0.0013678769,0.9982552,0.000094531446,0.00014703501,0.000037695867,0.000012255049,0.000034894314,0.0000013307356,0.00004917875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876106,0.00039484733,0.0004635096,0.00011684807,0.00023025223,0.000033433724],"domain_scores_gemma":[0.99557906,0.0032604975,0.00056414783,0.00007837966,0.0004449664,0.000073011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025328444,0.000692479,0.0026912317,0.0037319488,0.00027686416,0.0011326936,0.0011849197,0.00075142557,0.0037036475],"category_scores_gemma":[0.0076673105,0.00035325435,0.0015714242,0.005011435,0.00045337997,0.0011011275,0.0006436485,0.00074231194,0.00052418426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025770548,0.000041031,0.0004035754,0.4689871,0.001791306,0.000311101,0.00025990757,0.0002526132,0.00069306936,0.0008526582,0.01457497,0.511575],"study_design_scores_gemma":[0.00019326457,0.0005422152,0.005271098,0.43680692,0.01439811,0.0037920664,0.0004587525,0.0001256817,0.0007347811,0.0010409949,0.53656226,0.00007388081],"about_ca_topic_score_codex":0.0016739699,"about_ca_topic_score_gemma":0.0043678405,"teacher_disagreement_score":0.0037319488,"about_ca_system_score_codex":0.00075290963,"about_ca_system_score_gemma":0.0022110296,"threshold_uncertainty_score":0.013395071},"labels":[],"label_agreement":null},{"id":"W4391723324","doi":"10.1080/1120009x.2024.2313908","title":"<i>In vitro</i> killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital; Saskatchewan Health Authority","funders":"Royal University Hospital Foundation","keywords":"Amikacin; Microbiology; Antibiotics; Drug resistance; Drug; Acinetobacter baumannii; Medicine; Pseudomonas aeruginosa; Pharmacology; Staphylococcus aureus; Biology; Bacteria","score_opus":0.005954199682156071,"score_gpt":0.2508076887464087,"score_spread":0.2448534890642526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391723324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753499,0.007154564,0.008239337,0.00032407366,0.00013390828,0.00012616161,0.0017125048,0.000104174556,0.006855316],"genre_scores_gemma":[0.9871442,0.0027809972,0.0067134877,0.00011098165,0.000042356478,0.00009195281,0.0010852538,0.000015249045,0.002015495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993381,0.00023064666,0.000074838164,0.00008345003,0.00021065104,0.00006233351],"domain_scores_gemma":[0.9996723,0.000110560366,0.00007899871,0.00003163459,0.00009125533,0.0000152247785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002779027,0.00026353967,0.00028318135,0.00015198707,0.00013085487,0.000473538,0.00025119085,0.00026897603,0.0015744712],"category_scores_gemma":[0.0004896498,0.00011676804,0.0002681122,0.00022989063,0.00017536059,0.00027285455,0.00021786615,0.00041018755,0.00039017698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019329984,0.000087614084,0.0023505515,0.00027757796,0.000015410626,0.00004687793,0.00004305557,0.00035358433,0.9920975,0.00009073832,0.00019776364,0.004246105],"study_design_scores_gemma":[0.0000035869652,0.0011672109,0.007438634,0.000021138942,0.0000170877,0.00016511681,0.00005839071,0.0009534604,0.9885083,0.00003387869,0.0016240886,0.000009184199],"about_ca_topic_score_codex":0.0007730854,"about_ca_topic_score_gemma":0.0009406046,"teacher_disagreement_score":0.0015744712,"about_ca_system_score_codex":0.0001803436,"about_ca_system_score_gemma":0.00014080439,"threshold_uncertainty_score":0.0052670836},"labels":[],"label_agreement":null},{"id":"W4399221811","doi":"10.1080/1120009x.2024.2359838","title":"Elevated CK from immune checkpoint inhibitor- related hypophysitis: a case report","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Muscle and Compartmental Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Hypophysitis; Medicine; Cancer research; Internal medicine; Pituitary gland","score_opus":0.010774405562299496,"score_gpt":0.27351564096458975,"score_spread":0.2627412354022903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399221811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9389192,0.023772018,0.008764208,0.012010268,0.0016863721,0.000465736,0.00053377746,0.00049690896,0.01335154],"genre_scores_gemma":[0.9914657,0.0028836702,0.001748761,0.0013986665,0.0014089221,0.00003682608,0.00009563416,0.0000312912,0.0009305273],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986804,0.0001266816,0.00016065864,0.0004502044,0.00018818562,0.0003938223],"domain_scores_gemma":[0.99766976,0.00058026996,0.0004957701,0.00023605797,0.00013028628,0.0008877998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055534893,0.0030451235,0.0021352447,0.004310057,0.0031412512,0.002634905,0.0019041299,0.00821623,0.0024403504],"category_scores_gemma":[0.0035275107,0.0020822384,0.0021939143,0.0024883377,0.0028159705,0.0043893536,0.002833311,0.006255575,0.0011624752],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020043406,0.000039013372,0.0022677504,0.000033238284,0.0000112226035,0.99603444,0.00010641578,0.00006274473,0.00043350816,0.00011636305,0.00020844062,0.0006668309],"study_design_scores_gemma":[0.000010320886,0.000035187037,0.0015666255,0.00001543036,0.0000101410105,0.9975802,0.000078175006,0.00016327476,0.00017479311,0.00010605561,0.00024978953,0.000010027062],"about_ca_topic_score_codex":0.003466186,"about_ca_topic_score_gemma":0.0033657358,"teacher_disagreement_score":0.00821623,"about_ca_system_score_codex":0.00279167,"about_ca_system_score_gemma":0.0014399908,"threshold_uncertainty_score":0.020255089},"labels":[],"label_agreement":null},{"id":"W4402582237","doi":"10.1080/1120009x.2024.2402177","title":"Reversible chemoresistance of pancreatic cancer grown as spheroids","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health; Rolfe Pancreatic Cancer Foundation; Johns Hopkins University","keywords":"Spheroid; Pancreatic cancer; Cancer; Cancer research; Oncology; Internal medicine; Medicine; Biology; Genetics; Cell culture","score_opus":0.02158684788261269,"score_gpt":0.35631920965416713,"score_spread":0.33473236177155447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402582237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737191,0.0045543094,0.013736203,0.0002525765,0.00016057095,0.00016382337,0.0026984252,0.00033443782,0.00438052],"genre_scores_gemma":[0.97970015,0.0024293857,0.011203046,0.00014278264,0.000015401169,0.00012253481,0.0021922986,0.00006490996,0.0041294615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999853,0.000028647328,0.000021386728,0.000038360507,0.00004251843,0.00001603762],"domain_scores_gemma":[0.9998654,0.00004156559,0.000028375991,0.000031454743,0.000016986907,0.000016114353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014052057,0.00030381282,0.00036179074,0.00018821564,0.00016184137,0.00031119087,0.00010153181,0.00019122589,0.00073832436],"category_scores_gemma":[0.0001133771,0.00013227726,0.00028036785,0.00023176044,0.00015569942,0.000234369,0.0001943404,0.0004942851,0.00030060575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024412237,0.000009792467,0.0002307843,0.000033369197,0.0000071115583,0.0000555179,0.000026345724,0.00016088232,0.99815756,0.000046987392,0.00011512532,0.0011321062],"study_design_scores_gemma":[0.0000071931336,0.00025896617,0.00576686,0.000008275551,0.000023640596,0.00031549516,0.000054715198,0.0013411875,0.9870543,0.000051154046,0.005112308,0.0000059750323],"about_ca_topic_score_codex":0.0011128241,"about_ca_topic_score_gemma":0.002032889,"teacher_disagreement_score":0.0011128241,"about_ca_system_score_codex":0.00027717714,"about_ca_system_score_gemma":0.00018049724,"threshold_uncertainty_score":0.0024699569},"labels":[],"label_agreement":null},{"id":"W4403431163","doi":"10.1080/1120009x.2024.2416348","title":"Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy","year":2024,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Hypertrophic osteoarthropathy and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hypertrophic osteoarthropathy; Medicine; Immune system; Dermatology; Immunology","score_opus":0.010722749265720564,"score_gpt":0.250693520089474,"score_spread":0.23997077082375343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403431163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96266514,0.009575344,0.004376503,0.0037048582,0.00045125483,0.0002267677,0.0002688796,0.00027478224,0.01845654],"genre_scores_gemma":[0.99451715,0.001384234,0.0012195109,0.0006975148,0.0007077804,0.000023343951,0.000060573166,0.000014067299,0.001375821],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99948955,0.00006880883,0.000051126193,0.00013112879,0.000075364005,0.00018400821],"domain_scores_gemma":[0.99882764,0.0003090662,0.00032902998,0.0001441063,0.00007704941,0.0003131107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032774862,0.0014548738,0.00093223574,0.0012727118,0.002138254,0.0011935169,0.00085226615,0.0036084808,0.0022735372],"category_scores_gemma":[0.0017619921,0.0007089498,0.0009933241,0.0010769377,0.0012644816,0.0013485587,0.0010191833,0.0019525329,0.0007607663],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034360575,0.000038865965,0.006284298,0.00002195073,0.000008241994,0.99140465,0.000088097826,0.00003886641,0.0004957665,0.00008800495,0.00021056818,0.0012863829],"study_design_scores_gemma":[0.000008885705,0.000031097145,0.001659964,0.000005791962,0.00000676328,0.99774677,0.000038604958,0.00007398942,0.00013270133,0.000054594366,0.00023753077,0.0000033947604],"about_ca_topic_score_codex":0.0016478553,"about_ca_topic_score_gemma":0.0023672972,"teacher_disagreement_score":0.0036084808,"about_ca_system_score_codex":0.00065568293,"about_ca_system_score_gemma":0.0005819277,"threshold_uncertainty_score":0.0076057315},"labels":[],"label_agreement":null},{"id":"W4414306402","doi":"10.1080/1120009x.2025.2561969","title":"Characterizing pulmonary adverse events associated with the immune checkpoint inhibitor avelumab: a FAERS-based pharmacovigilance study from 2013 to 2024","year":2025,"lang":"en","type":"article","venue":"Journal of Chemotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pneumonitis; Adverse effect; Pneumonia; Pharmacovigilance; Respiratory distress; Respiratory failure; Pulmonary edema; Lung cancer; Pulmonary toxicity","score_opus":0.011283008644933243,"score_gpt":0.28717363617491565,"score_spread":0.2758906275299824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414306402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987917,0.0023059533,0.0011924811,0.0003414286,0.000019197138,0.00010067649,0.0065364637,0.000043173874,0.0015436091],"genre_scores_gemma":[0.994655,0.00025796896,0.00048811393,0.00025243257,0.00002881907,0.000057123227,0.0039996477,0.000009837227,0.00025116012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965162,0.0012305253,0.0006481291,0.00060906913,0.0007284061,0.00026763184],"domain_scores_gemma":[0.9887411,0.0027045177,0.0061271978,0.0008756431,0.0011541526,0.00039735757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054321885,0.0002366463,0.00042927865,0.0010372669,0.0002690594,0.00090482866,0.00033940742,0.00043874496,0.0014133528],"category_scores_gemma":[0.010588427,0.00018266926,0.0014356552,0.0013440473,0.00022269879,0.00065470533,0.0006879485,0.00057603937,0.00018555135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028371054,0.00006983883,0.9830988,0.000108910775,0.00088829495,0.00015476301,0.00007923245,0.000527285,0.00065296283,0.00008725292,0.00086766796,0.010627803],"study_design_scores_gemma":[0.000115573916,0.00057959574,0.9936499,0.00006539186,0.0006606392,0.0005792573,0.00007391505,0.0013307945,0.0007634574,0.00010923571,0.002056732,0.00001555372],"about_ca_topic_score_codex":0.0055803433,"about_ca_topic_score_gemma":0.0072173756,"teacher_disagreement_score":0.0055803433,"about_ca_system_score_codex":0.0010828184,"about_ca_system_score_gemma":0.0010174913,"threshold_uncertainty_score":0.028728485},"labels":[],"label_agreement":null},{"id":"W68924427","doi":"10.1080/1120009x.2004.11782371","title":"The Role of PK/PD Parameters to Avoid Selection and Increase of Resistance: Mutant Prevention Concentration","year":2004,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"Allergan","keywords":"Levofloxacin; Moxifloxacin; Gemifloxacin; Gatifloxacin; Antimicrobial; Streptococcus pneumoniae; Microbiology; Minimum inhibitory concentration; Ciprofloxacin; Population; Pseudomonas aeruginosa; Drug resistance; Ofloxacin; Bacterial growth; Biology; Bacteria; Antibiotics; Medicine","score_opus":0.008633022891772063,"score_gpt":0.29006403431515493,"score_spread":0.2814310114233829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W68924427","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4524818,0.14831161,0.3520236,0.00671871,0.0007659892,0.0013172753,0.0009350472,0.0040014284,0.033444554],"genre_scores_gemma":[0.9486302,0.01044788,0.036290612,0.0015396766,0.00016819609,0.00038225125,0.0002531094,0.0002357948,0.0020522443],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985697,0.000537434,0.000113596485,0.00029647647,0.0003599325,0.00012277695],"domain_scores_gemma":[0.9964818,0.00173289,0.00082206604,0.00023659112,0.0005188331,0.00020784033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022883955,0.0013871691,0.001707544,0.00057810935,0.00032399013,0.0033101959,0.0011867078,0.0016105314,0.0018074275],"category_scores_gemma":[0.009195687,0.00050965545,0.0005139741,0.00040238645,0.0009069346,0.0024926625,0.0008197543,0.001787605,0.0013513454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005365705,0.001697465,0.020035893,0.0031623263,0.00043805325,0.00058414595,0.00038416858,0.044018503,0.5294855,0.007524691,0.004780269,0.38252333],"study_design_scores_gemma":[0.00077922514,0.014554893,0.03810318,0.0008689242,0.0007664497,0.007453715,0.0003877618,0.22229207,0.63195884,0.01602685,0.0664158,0.00039231445],"about_ca_topic_score_codex":0.0005636493,"about_ca_topic_score_gemma":0.00031529772,"teacher_disagreement_score":0.0033101959,"about_ca_system_score_codex":0.0011473104,"about_ca_system_score_gemma":0.0009135877,"threshold_uncertainty_score":0.0121023655},"labels":[],"label_agreement":null}]}